BPG is committed to discovery and dissemination of knowledge
Featured Articles
9/20/2022 11:19:57 AM | Browse: 29 | Download: 25
Publication Name World Journal of Psychiatry
Manuscript ID 77052
Country/Territory Germany
2022-04-13 07:57
Peer-Review Started
2022-04-13 08:00
To Make the First Decision
Return for Revision
2022-06-11 05:54
2022-06-26 02:13
Second Decision
2022-08-08 03:13
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2022-08-18 00:07
Articles in Press
2022-08-18 00:07
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2022-09-07 13:53
Publish the Manuscript Online
2022-09-20 11:01
ISSN 2220-3206 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Psychiatry
Manuscript Type Editorial
Article Title Suicidal Behavior – Advances in Clinical and Neurobiological Research and Improvement of Prevention Strategies
Manuscript Source Invited Manuscript
All Author List Thomas Sobanski, Gregor Peikert, Ulrich W Kastner and Gerd Wagner
Funding Agency and Grant Number
Corresponding Author Thomas Sobanski, MD, Chief Doctor, Senior Lecturer, Senior Research Fellow, Department of Psychiatry, Psychotherapy, and Psychosomatic Medicine, THUERINGEN-Kliniken GmbH, 68 Rainweg, Saalfeld 07318, Germany. sobanskit@aol.com
Key Words Antidepressants; Biomarkers; Cognitive behavioral therapy; Esketamine; Prevention; Suicidal behavior
Core Tip This Editorial highlights recent developments concerning suicide prevention. According to current research, measures such as restricting access to lethal means and school-based awareness programs are the most efficacious universal prevention strategies. Novel psychological screening methods for suicidal behavior (implicit cognition, smartphone-based interventions, and real-time monitoring) have improved suicide risk assessment. Pharmacoepidemiological studies and meta-analyses support a protective role of antidepressants, lithium, and clozapine. Promising results exist for ketamine in reducing suicidal ideation. However, its suicide-preventive effect is under debate. Specific psychotherapeutic approaches for suicide attempters laying the focus on suicidal episodes proved to be efficacious for reducing suicide re-attempts.
Publish Date 2022-09-20 11:01
Citation Sobanski T, Peikert G, Kastner UW, Wagner G. Suicidal behavior-advances in clinical and neurobiological research and improvement of prevention strategies. World J Psychiatry 2022; 12(9): 1115-1126
URL https://www.wjgnet.com/2220-3206/full/v12/i9/1115.htm
DOI https://dx.doi.org/10.5498/wjp.v12.i9.1115
Full Article (PDF) WJP-12-1115.pdf
Full Article (Word) WJP-12-1115.docx
Manuscript File 77052_Auto_Edited-LS.docx
Answering Reviewers 77052-Answering reviewers.pdf
Audio Core Tip 77052-Audio core tip.wav
Conflict-of-Interest Disclosure Form 77052-Conflict-of-interest statement.pdf
Copyright License Agreement 77052-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 77052-Language certificate.pdf
Peer-review Report 77052-Peer-review(s).pdf
Scientific Misconduct Check 77052-Bing-Chen YL-2.png
Scientific Editor Work List 77052-Scientific editor work list.pdf